Medicinova Inc(MNOV)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
MNOV is scheduled to report on Nov 11, 2026, usually after the market closes. Analysts expect EPS of -$0.06.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±3.2%).
Did the stock rise after good news?
The next-day move after each of its last 9 EPS beats and 2 misses.
In plain words: it beat expectations 9 times, but the stock still fell 6 of those 9 times.
- Aug '26Beat▼ 0.0%
- May '26Beat▼ -1.4%
- Feb '26Beat▼ -3.2%
- Nov '25Beat▼ -1.9%
- Aug '25Beat▲ +0.8%
- May '25Beat▼ -6.2%
- Feb '25Missed▼ -9.6%
- Aug '24Beat▲ +0.9%
- May '24Missed▲ +4.8%
- Feb '24Beat▲ +0.7%
- Nov '23Beat▼ -0.6%
Clear beats and misses with a known reaction only. What counts as a beat
Why did MNOV fall after beating earnings?
6 of MNOV's last 11 reactions went against the EPS result. What stands out in each:
MNOV beat EPS estimates in 9 quarters, and the stock still closed lower the next day 5 times. In 1 of the 5 where we have price data, the stock had already run up before the report.
- May 14, 2026EPS beat +16.7%stock -1.4% next day
Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.
- Feb 20, 2026EPS beat +44.4%stock -3.2% next day
- It opened 2.6% higher, but sellers took over and it closed -3.2%.
- Nov 12, 2025EPS beat +50.0%stock -1.9% next day
- It had risen 26.6% in the 20 trading sessions before the report, so good news may already have been priced in.
- It opened 2.5% lower as soon as trading resumed.
- May 13, 2025EPS beat +57.1%stock -6.2% next day
- It opened 3.4% higher, but sellers took over and it closed -6.2%.
- Nov 9, 2023EPS beat +87.5%stock -0.6% next day
- It opened 2.8% higher, but sellers took over and it closed -0.6%.
Rose despite an EPS miss (1 of 2)
- May 9, 2024EPS missed -20.0%stock +4.8% next day
- It had already fallen 6.4% in the 20 trading sessions before the report, so weak results may have been expected.
- It opened 1.4% higher as soon as trading resumed.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was MNOV's earnings move already priced in?
MNOV's move in the month before each of its last 12 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 12 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does MNOV hold its opening gap after earnings?
MNOV's opening move after each report and where it closed that day.
In 8 reports MNOV opened at least 1% away from the previous close. It gave back half or more of that gap by the close 5 of 8 times (63%), and fully reversed 5 times. Gaps up faded 4 of 5; gaps down recovered 1 of 3.
- Feb 20, 2026ReversedOpened +2.6%, closed -3.2%
- Nov 12, 2025HeldOpened -2.5%, closed -1.9%
- Aug 14, 2025ReversedOpened -1.5%, closed +0.8%
- May 13, 2025ReversedOpened +3.4%, closed -6.2%
- Feb 19, 2025HeldOpened -4.1%, closed -9.6%
- Nov 13, 2024ReversedOpened +4.5%, closed -8.5%
- May 9, 2024HeldOpened +1.4%, closed +4.8%
- Nov 9, 2023ReversedOpened +2.8%, closed -0.6%
What the history says
- MNOV has beaten EPS estimates in 6 straight quarters.
- It fell after 5 of its 9 EPS beats (56%): beating estimates has not been enough on its own.
MNOV earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|
| Aug 13, 2026 | After close | -$0.06 | -$0.05 | +16.7% | 0.00% | +2.29% |
| May 14, 2026 | After close | -$0.06 | -$0.05 | +16.7% | -1.43% | -1.43% |
| Feb 20, 2026 | Before open | -$0.09 | -$0.05 | +44.4% | -3.23% | -12.90% |
| Nov 12, 2025 | After close | -$0.12 | -$0.06 | +50.0% | -1.91% | -10.19% |
| Aug 14, 2025 | After close | -$0.12 | -$0.07 | +41.7% | +0.77% | 0.00% |
| May 13, 2025 | After close | -$0.14 | -$0.06 | +57.1% | -6.16% | -9.59% |
| Feb 19, 2025 | After close | -$0.05 | -$0.06 | -20.0% | -9.64% | -10.66% |
| Nov 13, 2024 | After close | -$0.06 | -$0.06 | 0.0% | -8.50% | -10.00% |
| Aug 8, 2024 | After close | -$0.06 | -$0.05 | +16.7% | +0.87% | -1.74% |
| May 9, 2024 | After close | -$0.05 | -$0.06 | -20.0% | +4.79% | +1.37% |
| Feb 15, 2024 | After close | -$0.08 | -$0.04 | +50.0% | +0.74% | 0.00% |
| Nov 9, 2023 | After close | -$0.08 | -$0.01 | +87.5% | -0.56% | -2.79% |
Consensus for the next report: EPS -$0.06, revenue $51,000.00.
MNOV Earnings FAQ
Answers computed from Medicinova Inc's reported history
MNOV is scheduled to report on Nov 11, 2026, usually after the market closes. Analysts expect EPS of -$0.06.
Over the last 12 quarters with a usable EPS surprise, MNOV beat the consensus estimate 9 times (75%), missed 2 and landed in line 1. It has beaten estimates in each of the last 6 counted quarters.
Across its last 12 quarters with a measured reaction, MNOV moved an average of ±3.2% in the first session after reporting. It closed higher 33% of the time; the largest gain was 4.8% and the largest drop -9.6%.
MNOV fell in the first session after 5 of its last 9 EPS beats (56%). A beat that was already priced in, or weaker guidance, can send a stock lower. In 1 of the 5 of those falls where price data is available, the stock had already risen before the report.
Across its last 12 quarters with price data, MNOV moved an average of -1.0% in the 20 trading sessions before reporting and was higher in 42% of them. After a run-up of 3% or more (5 quarters), it fell the next day 80% of the time, averaging -5.1%. After a drop of 3% or more (6 quarters), it rose the next day 50% of the time, averaging +0.4%. This describes past reports; it is not a forecast.
In 8 reports MNOV opened at least 1% away from the previous close. It gave back half or more of that gap by the close 5 of 8 times (63%), and fully reversed 5 times. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · MNOV: 12 reported quarters, latest Aug 13, 2026. Information only, not investment advice.
Looking for more on MNOV?
Price charts, forecast, fundamentals and risk pages for MNOV are not on Tickzen yet. You can run a full stock analysis now.
Run the MNOV Stock AnalyzerLatest TickZen Insights
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun
Coca-Cola (KO) Q3 2026 Earnings Preview: Can Growth Justify Its Valuation?By Vishal Jadaun
Welltower Q3 2026 Earnings Preview: Can 20% Senior Housing Growth Last?By Vishal Jadaun